Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charité Ricker

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
JCO Precision Oncology|October 28, 2023
Exploring Stakeholders' Perspectives on Implementing Universal Germline Testing for Colorectal Cancer: Findings From a Clinical Practice SurveyLinda Rodgers-Fouche, Sanjeevani Arora, Charité Ricker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 15, 2020
Management of Male Breast Cancer: ASCO GuidelineMichael J Hassett, Mark R Somerfield, Elisha R Baker, et al.
Cancer|June 18, 2019
Pathogenic and likely pathogenic variants in PALB2, CHEK2, and other known breast cancer susceptibility genes among 1054 BRCA-negative Hispanics with breast cancerJeffrey N Weitzel, Susan L Neuhausen, Aaron Adamson, et al.
JCO Precision Oncology|February 17, 2022
Unexpected <i>CDH1</i> Mutations Identified on Multigene Panels Pose Clinical Management ChallengesKatrina Lowstuter, Carin R Espenschied, Duveen Sturgeon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 13, 2012
Prevalence and type of BRCA mutations in Hispanics undergoing genetic cancer risk assessment in the southwestern United States: a report from the Clinical Cancer Genetics Community Research NetworkJeffrey N Weitzel, Jessica Clague, Arelis Martir-Negron, et al.
Medrxiv : the Preprint Server for Health Sciences|February 7, 2023
Whole exome sequencing and replication for breast cancer among Hispanic/Latino women identifies <i>FANCM</i> as a susceptibility gene for estrogen-receptor-negative breast cancerJovia L Nierenberg, Aaron W Adamson, Donglei Hu, et al.
JAMA Network Open|January 13, 2025
Breast Cancer MRI Screening of Patients After Multiplex Gene Panel TestingLeah A Naghi, Julie O Culver, Charité Ricker, et al.
Journal of Cancer Research and Clinical Oncology|November 19, 2020
PD-1 inhibition therapy for advanced cutaneous squamous cell carcinoma: a retrospective analysis from the University of Southern CaliforniaGino K In, Poorva Vaidya, Alexandra Filkins, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 17, 2024
Selection of Germline Genetic Testing Panels in Patients With Cancer: ASCO GuidelineNadine Tung, Charité Ricker, Hans Messersmith, et al.
Annals of Surgical Oncology|September 26, 2022
Integration of Universal Germline Genetic Testing for All New Breast Cancer PatientsJulie O Culver, Yael Freiberg, Charité Ricker, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
JCO Precision Oncology|October 28, 2023
Exploring Stakeholders' Perspectives on Implementing Universal Germline Testing for Colorectal Cancer: Findings From a Clinical Practice SurveyLinda Rodgers-Fouche, Sanjeevani Arora, Charité Ricker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 15, 2020
Management of Male Breast Cancer: ASCO GuidelineMichael J Hassett, Mark R Somerfield, Elisha R Baker, et al.
Cancer|June 18, 2019
Pathogenic and likely pathogenic variants in PALB2, CHEK2, and other known breast cancer susceptibility genes among 1054 BRCA-negative Hispanics with breast cancerJeffrey N Weitzel, Susan L Neuhausen, Aaron Adamson, et al.
JCO Precision Oncology|February 17, 2022
Unexpected <i>CDH1</i> Mutations Identified on Multigene Panels Pose Clinical Management ChallengesKatrina Lowstuter, Carin R Espenschied, Duveen Sturgeon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 13, 2012
Prevalence and type of BRCA mutations in Hispanics undergoing genetic cancer risk assessment in the southwestern United States: a report from the Clinical Cancer Genetics Community Research NetworkJeffrey N Weitzel, Jessica Clague, Arelis Martir-Negron, et al.
Medrxiv : the Preprint Server for Health Sciences|February 7, 2023
Whole exome sequencing and replication for breast cancer among Hispanic/Latino women identifies <i>FANCM</i> as a susceptibility gene for estrogen-receptor-negative breast cancerJovia L Nierenberg, Aaron W Adamson, Donglei Hu, et al.
JAMA Network Open|January 13, 2025
Breast Cancer MRI Screening of Patients After Multiplex Gene Panel TestingLeah A Naghi, Julie O Culver, Charité Ricker, et al.
Journal of Cancer Research and Clinical Oncology|November 19, 2020
PD-1 inhibition therapy for advanced cutaneous squamous cell carcinoma: a retrospective analysis from the University of Southern CaliforniaGino K In, Poorva Vaidya, Alexandra Filkins, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 17, 2024
Selection of Germline Genetic Testing Panels in Patients With Cancer: ASCO GuidelineNadine Tung, Charité Ricker, Hans Messersmith, et al.
Annals of Surgical Oncology|September 26, 2022
Integration of Universal Germline Genetic Testing for All New Breast Cancer PatientsJulie O Culver, Yael Freiberg, Charité Ricker, et al.
Pageof 4